Alnylam Pharmaceuticals
ALNY
#581
Rank
โ‚ฌ32.16 B
Marketcap
248,55ย โ‚ฌ
Share price
-0.94%
Change (1 day)
79.52%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) Fails to deliver data

Key failure to deliver metrics for Alnylam Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Alnylam Pharmaceuticals (ALNY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Alnylam Pharmaceuticals (ALNY) - since 2013

Volume in USD (price x number of shares), data since 2013

Alnylam Pharmaceuticals (ALNY) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚ฌ5.32 M-87.67%
2024โ‚ฌ43.18 M-16.96%
2023โ‚ฌ51.99 M-66.55%
2022โ‚ฌ0.15 B200.46%
2021โ‚ฌ51.74 M-9.83%
2020โ‚ฌ57.38 M52.34%
2019โ‚ฌ37.66 M46.52%
2018โ‚ฌ25.7 M-70.97%
2017โ‚ฌ88.54 M191.96%
2016โ‚ฌ30.32 M-14.94%
2015โ‚ฌ35.65 M68.07%
2014โ‚ฌ21.21 M152.1%
2013โ‚ฌ8.41 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚ฌ3.12 Mโ‚ฌ10.05 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ25.08 Mโ‚ฌ50.67 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.5 Mโ‚ฌ36.16 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.94 Mโ‚ฌ53.85 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.19 Mโ‚ฌ6.67 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ22.68 Mโ‚ฌ0.15 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ6.86 Mโ‚ฌ53.59 M๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ13.08 Mโ‚ฌ42.43 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel